Drawing for AVANIA

USPTO serial 88600290

AVANIA

Reviewed by CopyMark Law Group

Reg. 6071106Status 702Renewal
Filing date
Status date
Registration date
Jun 2, 2020
Examiner
OPUTA, CHIOMA N
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with AVANIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roberto Ledesma

Roberto Ledesma Law Office of Roberto LedesmaP.O. Box 230692New York, NY 10023United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management; Medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; Business consulting services in the field of medical coding in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; Providing reimbursement services, namely, providing business advice and information relating to reimbursement strategies and support to companies involved in the healthcare fieldACTIVEMar 2, 2020
041Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reportsACTIVEMar 2, 2020
042Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, including orthopedic, cardiovascular, dermatology, and aesthetics; consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the Food and Drug Administration (FDA) by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devicesACTIVEMar 2, 2020
045Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fieldsACTIVEMar 2, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 21, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 21, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 21, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 20, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Feb 11, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 2, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 24, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 24, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 24, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 24, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 24, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 24, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 20, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 20, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 20, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 20, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 9, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 2, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 30, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 29, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 3, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 3, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 17, 2020IUAFUSE AMENDMENT FILED—
Mar 17, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 17, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 13, 2019ALIEASSIGNED TO LIE—
Dec 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 10, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 10, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 10, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 4, 2019DOCKASSIGNED TO EXAMINER—
Sep 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance